4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-023069
CBO & COO sold 100,000 shares at an average $128.05 ($12,805,240)
- CBO & COO acquired 88,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise | +12,000 | $44.67 | $536,040 | 25,050 | D: show line 1 in the form |
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise | +22,000 | $51.49 | $1,132,780 | 47,050 | D: show line 2 in the form |
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise | +10,000 | $29.87 | $298,700 | 57,050 | D: show line 3 in the form |
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise | +20,000 | $40.87 | $817,400 | 77,050 | D: show line 4 in the form |
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise | +12,000 | $14.43 | $173,160 | 89,050 | D: show line 5 in the form |
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise | +12,000 | $17.66 | $211,920 | 101,050 | D: show line 6 in the form |
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Sale | −88,000 | $128.20 | $11,281,600 | 13,050 | D: show line 7 in the form |
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Sale | −12,000 | $126.97 | $1,523,640 | 1,050 | D: show line 8 in the form |
| Open-market sales · 100,000 sh · avg $128.05 · $12,805,240 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise · Stock Option (Right to Buy) | −12,000 | 2,666 | D: show line 9 in the form | ||
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise · Stock Option (Right to Buy) | −12,000 | 3,000 | D: show line 10 in the form | ||
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise · Stock Option (Right to Buy) | −22,000 | 38,000 | D: show line 11 in the form | ||
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise · Stock Option (Right to Buy) | −10,000 | 10,000 | D: show line 12 in the form | ||
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise · Stock Option (Right to Buy) | −20,000 | 25,000 | D: show line 13 in the form | ||
| Klein Lawrence Otto CBO & COO | 2021-03-23 | Option exercise · Stock Option (Right to Buy) | −12,000 | 43,000 | D: show line 14 in the form |
Loading xslF345X03/doc4.xml…